Analyst Ratings for Abbvie (abbv)
abbv Rating Summary
abbv Price Target Summary
- Highest: $300.00 (BMO Capital)
- Lowest: $204.00 (Deutsche Bank)
- Average: $267.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$267.80 (+3.4%)
* Over Last 12-Mos
Rating Score: 7.2 / 10
Percentile Rank: 76%
Avg. $ Target:
$267.80 (+3.4%)
* Over Last 12-Mos
Rating Score: 7.2 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/13/2026 | Wolfe Research | Alexandria Hammond | Upgrade | Outperform (Peerperform) |
300.00 (N/A) |
248.76 (258.92) |
4.08% | Details |
| 8/5/2026 | Erste Group | Hans Engel | Upgrade | Buy (Hold) |
N/A (N/A) |
243.80 (258.92) |
6.2% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


